Long-term Follow-up of Depressive Disorders in Psychiatric Care

Launched by REGION SKANE · Jul 13, 2025

Keywords

ClinConnect Summary

This study is looking at people with depression that is hard to treat, to better understand how their condition develops over time and what factors might predict how well treatments work. The researchers are following up with a group of 415 patients who were first studied between 2012 and 2021. These patients had detailed check-ups and genetic testing related to how their bodies process certain medications. Now, the study will review their medical records and other health information for five years after their original participation to learn more about their symptoms, treatment progress, and risk of suicide.

To take part in this follow-up study, patients must have been part of the earlier study focused on depression, suicide attempts, and genetics. Anyone who does not want to join the follow-up can choose not to participate. This study is open to adults of all genders, and it aims to improve future care for people with difficult-to-treat depression by finding better ways to predict and manage the condition over the long term. Participants won’t need to attend new appointments but will have their existing health information reviewed to help researchers learn more.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participation in the study "Pharmacogenetics in depressive patients with specific focus on difficult-to-treat depression, suicide attempt and CYP2D6"
• Exclusion Criteria:
• • Not wanting to participate in the follow-up study